Covid: Centre reassures Covishield’s safety, explains how to stop virus mutation
NITI Aayog Member (Health) V K Paul said there is adequate supplies of vaccines for inoculating those aged 45 and above.
"We have seamless connection with states.
There is no inadequacy of vaccine supply," he said.
"Active participation of the private sector has been very important for us but still there is a great room for improvement," Paul said as he appealed to the private sector partners to come forward to participate in the inoculation drive.
Responding to a question on blood clotting post vaccination, Paul said the committee which closely monitor adverse events following immunisation has "concluded that thrombosis events due to Covishield in India is not a problem".
Health Minister of Chhattisgarh, TS Singh Deo on May 08 said the state government will receive 3.50 lakh doses of Covishield today and the further vaccination will go on with this. "We received 1.50 lakh Covaxin doses from Bharat Biotech on May 1 and the vaccination is going on with that. We'll receive 3.50 lakh doses of Covishield today and the vaccination will further go on with this," Deo said media persons.
Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."
Responding to a question on whether nationwide lockdown is the only solution amid the rise in Covid cases, NITI Aayog member Doctor VK Paul said a detailed advisory has been issued to states and UTs to impose restrictions to break the chain of the virus. He said that states and UTs should make a careful analysis of the local situation and take the decision on lockdown. He added, “In addition to this range of restrictions, if anything more is required, those options are always being discussed and those decisions as required will be taken.” Watch the full video for more.
Credit: HT Digital Content Duration: 02:13Published
Replying to a question whether a nationwide lockdown is the only solution amid the rise in COVID-19 cases, NITI Aayog member Doctor VK Paul on May 05 said, "If anything more is required those options are always being discussed. There's already a guideline to states to impose restrictions to suppress chain of transmission."